Mechanisms of resistance to mTOR inhibitors-Reference-Cited by-同舟云学术

Mechanisms of resistance to mTOR inhibitors

Published:2020-03 Issue: Volume:147 Page:102886
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Formisano Luigi,Napolitano Fabiana^ORCID,Rosa Roberta,D’Amato Valentina,Servetto Alberto,Marciano Roberta,De Placido Pietro,Bianco Cataldo,Bianco Roberto

Funder

Associazione Italiana per la Ricerca sul Cancro

My First

Consorzio Interuniversitario Nazionale per la Bio-Oncologia

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference140 articles.

1. The mammalian target of rapamycin signaling pathway: twists and turns in the road to cancer therapy;Abraham;Clin. Cancer Res.,2007

2. Immunopharmacology of rapamycin;Abraham;Annu. Rev. Immunol.,1996

3. Everolimus in combination with Imatinib overcomes resistance in Chronic myeloid leukaemia;Alves;Med. Oncol.,2019

4. Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases;Apsel;Nat. Chem. Biol.,2008

5. Architecture of human mTOR complex 1;Aylett;Science (80-),2016

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Interplay between Autophagy and Mitochondria in Cancer;International Journal of Molecular Sciences;2024-08-23

2. The Cytoprotective and Cytotoxic Functions of Autophagy in Response to mTOR Inhibitors;Frontiers in Bioscience-Landmark;2024-06-24

3. Extracellular Matrix-Induced Genes May Reduce Response to Rapamycin in LAM;2024-05-19

4. DCAF1 interacts with PARD3 to promote hepatocellular carcinoma progression and metastasis by activating the Akt signaling pathway;Journal of Experimental & Clinical Cancer Research;2024-05-06

5. Simultaneous targeting of AMPK and mTOR is a novel therapeutic strategy against prostate cancer;Cancer Letters;2024-04